• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rare cutaneous toxicity of immune checkpoint inhibitors: A case of durvalumab-induced dermatomyositis.

作者信息

Coustal Cyrille, Du Thanh Aurélie, Roubille François, Assenat Eric, Maria Alexandre T J

机构信息

Department of Internal Medicine, Multi-Organic Diseases, Local Referral Center for Rare Auto-immune Diseases, Montpellier University Hospital, Montpellier, France.

Department of Dermatology, Montpellier University Hospital, Montpellier, France.

出版信息

Eur J Cancer. 2021 Sep;155:25-27. doi: 10.1016/j.ejca.2021.06.031. Epub 2021 Jul 29.

DOI:10.1016/j.ejca.2021.06.031
PMID:34332401
Abstract
摘要

相似文献

1
Rare cutaneous toxicity of immune checkpoint inhibitors: A case of durvalumab-induced dermatomyositis.免疫检查点抑制剂罕见的皮肤毒性：一例度伐利尤单抗诱导的皮肌炎病例
Eur J Cancer. 2021 Sep;155:25-27. doi: 10.1016/j.ejca.2021.06.031. Epub 2021 Jul 29.
2
Dermatomyositis associated with nivolumab therapy for melanoma: a case report and review of the literature.与纳武单抗治疗黑色素瘤相关的皮肌炎：一例病例报告及文献综述
Dermatol Online J. 2020 Aug 15;26(8):13030/qt4c21b068.
3
Immunotherapy-intensified paraneoplastic dermatomyositis.免疫疗法强化的副肿瘤性皮肌炎
Indian J Dermatol Venereol Leprol. 2021 Jan-Feb;88(1):93-96. doi: 10.25259/IJDVL_1306_20.
4
De novo cutaneous connective tissue disease temporally associated with immune checkpoint inhibitor therapy: A retrospective analysis.与免疫检查点抑制剂治疗存在时间关联的新发皮肤结缔组织病：一项回顾性分析。
J Am Acad Dermatol. 2021 Mar;84(3):864-869. doi: 10.1016/j.jaad.2020.10.054. Epub 2020 Oct 24.
5
Durvalumab and multiple sclerosis: a causal link or simple unmasking?度伐利尤单抗与多发性硬化症：因果关系还是单纯的暴露？
Eur J Clin Pharmacol. 2020 Dec;76(12):1773-1774. doi: 10.1007/s00228-020-02959-0. Epub 2020 Jul 13.
6
[Dermatomyositis with squamous cell carcinoma of the lungs secondary to nivolumab treatment: a case report].[因纳武单抗治疗继发肺鳞状细胞癌的皮肌炎：一例报告]
Rinsho Shinkeigaku. 2020 Nov 27;60(11):768-772. doi: 10.5692/clinicalneurol.cn-001443. Epub 2020 Oct 27.
7
[Immune Checkpoint Inhibitors-induced Myasthenia Gravis: From Diagnosis to Treatment].[免疫检查点抑制剂诱导的重症肌无力：从诊断到治疗]
Zhongguo Fei Ai Za Zhi. 2020 Aug 20;23(8):685-688. doi: 10.3779/j.issn.1009-3419.2020.102.25. Epub 2020 Aug 5.
8
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.度伐鲁单抗单药治疗及联合替西木单抗与化疗用于未经治疗的不可切除局部晚期或转移性尿路上皮癌患者（DANUBE）：一项随机、开放标签、多中心、III 期临床试验。
Lancet Oncol. 2020 Dec;21(12):1574-1588. doi: 10.1016/S1470-2045(20)30541-6. Epub 2020 Sep 21.
9
Advanced Lung Adenocarcinoma with Nivolumab-associated Dermatomyositis.伴有纳武单抗相关皮肌炎的晚期肺腺癌
Intern Med. 2018 Aug 1;57(15):2217-2221. doi: 10.2169/internalmedicine.9381-17. Epub 2018 Mar 9.
10
How can we manage the cardiac toxicity of immune checkpoint inhibitors?我们如何管理免疫检查点抑制剂的心脏毒性？
Expert Opin Drug Saf. 2021 Jun;20(6):685-694. doi: 10.1080/14740338.2021.1906860. Epub 2021 Apr 1.

引用本文的文献

1
Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies.现代靶向治疗和免疫治疗对皮肤恶性肿瘤患者的皮肤副作用
Cancers (Basel). 2023 Jun 9;15(12):3126. doi: 10.3390/cancers15123126.
2
Exploring the role of immune checkpoint inhibitors in the etiology of myasthenia gravis and Lambert-Eaton myasthenic syndrome: A systematic review.探索免疫检查点抑制剂在重症肌无力和兰伯特-伊顿肌无力综合征病因学中的作用：一项系统评价。
Front Neurol. 2023 Jan 9;13:1004810. doi: 10.3389/fneur.2022.1004810. eCollection 2022.
3
A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint Inhibitors.
大疱性类天疱疮作为免疫检查点抑制剂不良反应的单机构回顾性研究经验
Cancers (Basel). 2022 Nov 5;14(21):5451. doi: 10.3390/cancers14215451.
4
Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors: A Review Article.免疫检查点抑制剂相关的皮肤不良反应：一篇综述文章。
Curr Oncol. 2022 Apr 18;29(4):2871-2886. doi: 10.3390/curroncol29040234.
5
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by Durvalumab: A Case Report and Literature Review.度伐利尤单抗诱导的亚急性皮肤型红斑狼疮样皮疹：一例报告及文献复习
Clin Cosmet Investig Dermatol. 2022 Jan 13;15:51-62. doi: 10.2147/CCID.S344445. eCollection 2022.